Dr. Huff’s major research interests focus on the development of novel therapeutic approaches for the treatment of multiple myeloma and other plasma cell dyscrasias. Her current efforts are focused on the clinical translation of novel approaches targeting myeloma stem cells both biologically and immunologically, and on efforts to improve the efficacy and reduce the toxicity of allogeneic bone marrow transplantation for multiple myeloma and related disorders.
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.